Bionano Genomics, Inc. Inventory Write-down
Bionano Genomics, Inc. (BNGO) reported Inventory Write-down of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-03-23
- Bionano Genomics, Inc. inventory write-down for the quarter ending 2025-12-31 was $0.00.
- Bionano Genomics, Inc. inventory write-down for the quarter ending 2024-12-31 was $0.00.
- Bionano Genomics, Inc. inventory write-down for the quarter ending 2024-09-30 was $7.20M.
- Bionano Genomics, Inc. inventory write-down for the quarter ending 2023-12-31 was $0.00.
- Bionano Genomics, Inc. inventory write-down for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Bionano Genomics, Inc. inventory write-down for fiscal 2024 was $7.23M.
- Bionano Genomics, Inc. inventory write-down for fiscal 2023 was $0.00.
- Bionano Genomics, Inc. inventory write-down for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 10-K · filed 2026-03-23 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $7.20M derived: sum of 2 quarters · filed 2026-03-23 | $7.23M 10-K · filed 2026-03-23 | ||
| 2024-09-30 | $7.20M 10-Q · filed 2025-11-13 | $7.23M 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | ||||
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 | ||||
| 2020-12-31 | $126.00K 10-K · filed 2022-03-01 | $125.64K 10-K · filed 2021-03-23 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $0.00 10-K · filed 2021-03-23 | |||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $1.29M 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $1.29M 10-Q · filed 2019-11-07 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $364.44K 10-K · filed 2019-03-14 | |||
| 2017-09-30 | $364.44K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |